Johnson & Johnson: The New Brunswick, N.J.,...
From Times Staff and Wire Reports
Johnson & Johnson: The New Brunswick, N.J., conglomerate said third-quarter earnings rose 19% on strength in its three main segments: pharmaceutical, consumer and professional. Net income totaled $314 million on revenue of $2.9 billion, up 17%.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
